{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:41:57Z","timestamp":1789555317816,"version":"build-2803163510"},"reference-count":102,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Pharmacotherapy"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.amjopharm.2008.12.004","type":"journal-article","created":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T20:36:14Z","timestamp":1232570174000},"page":"269-288","source":"Crossref","is-referenced-by-count":64,"title":["Inappropriate sexual behaviors in cognitively impaired older individuals"],"prefix":"10.1016","volume":"6","author":[{"given":"David R.P.","family":"Guay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjopharm.2008.12.004_bib1","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1176\/appi.ajp.157.5.708","article-title":"Mental and behavioral disturbances in dementia: Findings from the Cache County Study on Memory in Aging","volume":"157","author":"Lyketsos","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/1099-1166(200101)16:1<39::AID-GPS269>3.0.CO;2-F","article-title":"Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments","volume":"16","author":"Margallo-Lana","year":"2001","journal-title":"Int J Geriatr Psychiatry"},{"issue":"Suppl 3","key":"10.1016\/j.amjopharm.2008.12.004_bib3","first-page":"497","article-title":"Behavioral and psychological signs and symptoms of dementia: A consensus statement on current knowledge and implications for research and treatment","volume":"8","author":"Finkel","year":"1996","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib4","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1176\/ajp.147.8.1049","article-title":"Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease","volume":"147","author":"Steele","year":"1990","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/002383099200500108","article-title":"Incontinence and troublesome behaviors predict institutionalization in dementia","volume":"5","author":"O'Donnell","year":"1992","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib6","doi-asserted-by":"crossref","first-page":"S338","DOI":"10.1093\/geronj\/46.6.S338","article-title":"Sexual relations in later life: A national study of married persons","volume":"46","author":"Marsiglio","year":"1991","journal-title":"J Gerontol"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0749-0690(18)30561-5","article-title":"Sexuality and aging: An overview","volume":"7","author":"Comfort","year":"1991","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib8","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/02699050600744137","article-title":"Challenges associated with the definition and assessment of inappropriate sexual behaviour amongst individuals with an acquired neurological impairment","volume":"20","author":"Johnson","year":"2006","journal-title":"Brain Inj"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3928\/0098-9134-19980401-11","article-title":"Addressing hypersexuality in Alzheimer's disease","volume":"24","author":"Kuhn","year":"1998","journal-title":"J Gerontol Nurs"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib10","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.12968\/bjon.2004.13.22.17271","article-title":"Hypersexuality and dementia: Dealing with inappropriate sexual expression","volume":"13","author":"Higgins","year":"2004","journal-title":"Br J Nurs"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib11","series-title":"Alzheimer's Disease and Marriage","author":"Wright","year":"1993"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00002093-199601020-00006","article-title":"Sexual behavioral changes in Alzheimer disease","volume":"10","author":"Derouesn\u00e9","year":"1996","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00002093-199903000-00009","article-title":"Inappropriate sexual behaviors in dementia: A preliminary report","volume":"13","author":"Tsai","year":"1999","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/pgmj.2004.028043","article-title":"Sexually inappropriate behaviour in demented elderly people","volume":"81","author":"Alagiakrishnan","year":"2005","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib15","doi-asserted-by":"crossref","first-page":"M325","DOI":"10.1093\/gerona\/51A.6.M325","article-title":"An observational study of sexual behavior in demented male patients","volume":"51","author":"Zeiss","year":"1996","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib16","first-page":"34","article-title":"Sexually inappropriate behaviors. Assessment necessitates careful medical and psychological evaluation and sensitivity","volume":"60","author":"Lesser","year":"2005","journal-title":"Geriatrics"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib17","first-page":"66","article-title":"Sexual behavior in residents with dementia. Guidelines explain how to respond","volume":"16","author":"Sloane","year":"1993","journal-title":"Contemp Longterm Care"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib18","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1093\/brain\/awh620","article-title":"Kleine-Levin syndrome: A systematic review of 186 cases in the literature","volume":"128","author":"Arnulf","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF01808825","article-title":"The Kluver-Bucy syndrome","volume":"139","author":"Gosc\u00ednski","year":"1997","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib20","first-page":"269","article-title":"The Kluver-Bucy syndrome","volume":"41","author":"Gosc\u00ednski","year":"1997","journal-title":"J Neurosurg Sci"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib21","first-page":"179","article-title":"Behavioral and psychiatric symptoms associated with Huntington's disease","volume":"65","author":"Cummings","year":"1995","journal-title":"Adv Neurol"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib22","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/jnnp.49.8.867","article-title":"Hypersexuality or altered sexual preference following brain injury","volume":"49","author":"Miller","year":"1986","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.parkreldis.2005.06.005","article-title":"Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy","volume":"11","author":"Klos","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00002826-198910000-00002","article-title":"Hypersexuality with antiparkinsonian therapy","volume":"12","author":"Uitti","year":"1989","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib25","first-page":"188","article-title":"Parkinson's disease and levodopa. A five-year follow-up and review","volume":"121","author":"Markham","year":"1974","journal-title":"West J Med"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib26","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.pnpbp.2006.05.012","article-title":"Hypersexual behaviour, frotteurism, and delusional jealousy in a young parkinsonian patient during dopaminergic therapy with pergolide: A rare case of iatrogenic paraphilia","volume":"30","author":"Cannas","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1440-1819.2007.01667.x","article-title":"Sexual disinhibition in schizophrenia possibly induced by risperidone and quetiapine","volume":"61","author":"Lam","year":"2007","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib28","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/sj.ijir.3901483","article-title":"Cabergoline treatment in men with psychogenic erectile dysfunction: A randomized, double-blind, placebo-controlled study","volume":"19","author":"Nickel","year":"2007","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib29","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1212\/WNL.58.5.831","article-title":"Cabergoline can increase penile erections and libido","volume":"58","author":"Wittstock","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/mds.870130338","article-title":"Clozapine for dopaminergicinduced paraphilias in Parkinson's disease","volume":"13","author":"Fernandez","year":"1998","journal-title":"Mov Disord"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.beem.2007.04.006","article-title":"The neurophysiology of sexual arousal","volume":"21","author":"Schober","year":"2007","journal-title":"Best Prac Res Clin Endocrinol Metab"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1749-6632.2003.tb07295.x","article-title":"The monoamine hypothesis for the pathophysiology of paraphilic disorders: An update","volume":"989","author":"Kafka","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1300\/J070v12n03_09","article-title":"Sex hormones, neurotransmitters, and psychopharmacological treatments in men with paraphilic disorders","volume":"12","author":"Saleh","year":"2003","journal-title":"J Child Sex Abus"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1176\/ajp.151.2.271","article-title":"Effects on behavior of modulation of gonadal function in men with gonadotropin-releasing hormone antagonists","volume":"151","author":"Loosen","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib35","unstructured":"Guay DR. Drug treatment of paraphilias. Clin Ther. In press."},{"issue":"Suppl 4","key":"10.1016\/j.amjopharm.2008.12.004_bib36","first-page":"1","article-title":"Discovery, development, mode of action, and clinical use of cyproterone acetate","volume":"3","author":"Neumann","year":"1975","journal-title":"J Int Med Res"},{"issue":"Suppl 4","key":"10.1016\/j.amjopharm.2008.12.004_bib37","first-page":"10","article-title":"Steroid chemistry","volume":"3","author":"Stitch","year":"1975","journal-title":"J Int Med Res"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib38","first-page":"337","article-title":"Aspects of androgen-dependent events as studied by antiandrogens","volume":"26","author":"Neumann","year":"1970","journal-title":"Rec Prog Hormone Res"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib39","doi-asserted-by":"crossref","first-page":"13648","DOI":"10.1074\/jbc.M611711200","article-title":"Crystal structure of the T877A human androgen receptor ligand-binding domain complexed to cyproterone acetate provides insight for ligand-induced conformational changes and structure-based drug design","volume":"282","author":"Bohl","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib40","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-0028-1094147","article-title":"The influence of antiandrogens on the excretion of FSH, LH, and 17-ketosteroids in males","volume":"3","author":"Vosbeck","year":"1971","journal-title":"Hormone Metab Res"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib41","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0022-4731(75)90310-6","article-title":"Antiandrogens in the treatment of sexual deviations of men","volume":"6","author":"Laschet","year":"1975","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib42","series-title":"Martindale: The Complete Drug Reference","first-page":"1644","article-title":"Cyproterone acetate, medroxyprogesterone acetate, leuprolide, triptorelin","year":"2007"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib43","first-page":"1803","article-title":"Antiandrogens in the treatment of acne and hirsutism","volume":"45","author":"Jurzyk","year":"1992","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib44","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/art.1780281108","article-title":"Hormone modulation in systemic lupus erythematosus. Preliminary clinical and hormone results with cyproterone acetate","volume":"28","author":"Jungers","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib45","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4088\/JCP.v59n0806e","article-title":"Irradiation therapy prevents gynecomastia in sex offenders treated with antiandrogens","volume":"59","author":"Eriksson","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/(SICI)1099-1557(199705)6:3<169::AID-PDS263>3.0.CO;2-3","article-title":"Safety of cyproterone acetate: Report of active surveillance","volume":"6","author":"Heinemann","year":"1997","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib47","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1478-3231.2007.01549.x","article-title":"Suspected cross-hepatotoxicity of flutamide and cyproterone acetate","volume":"27","author":"Miguel","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib48","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/j.1464-410X.2007.06859.x","article-title":"Venous thromboembolism and cyproterone acetate in men with prostate cancer: A study using the General Practice Research Database","volume":"99","author":"Seaman","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib49","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1520\/JFS2002089","article-title":"Osteoporosis associated with the treatment of paraphilias: A clinical review of seven case reports","volume":"48","author":"Grasswick","year":"2003","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib50","first-page":"39","article-title":"Cyproterone and hypersexuality","volume":"86","author":"Unger","year":"1977","journal-title":"N Z Med J"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib51","series-title":"Depo-subQ provera 104 (medroxyprogesterone acetate injectable suspension 104 mg\/0.65 mL) [package insert]","year":"2004"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib52","series-title":"Provera (medroxyprogesterone) [package insert]","year":"1998"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib53","series-title":"Depo-Provera Contraceptive Injection (medroxyprogesterone acetate injectable suspension) [package insert]","year":"2004"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib54","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/00016348109157816","article-title":"Pharmacokinetics of medroxyprogesterone acetate administered by oral and intramuscular route","volume":"101","author":"L\u00f8ber","year":"1981","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib55","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF00257410","article-title":"Medroxyprogesterone acetate (MPA) plasma levels after multiple high-dose administration in advanced cancer patients","volume":"11","author":"Camaggi","year":"1983","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib56","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/BF01059057","article-title":"Influence of route of administration on the pharmacokinetics of medroxyprogesterone","volume":"11","author":"Antal","year":"1983","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib57","first-page":"3297","article-title":"Role of human cytochrome P450 3A4 in metabolism of medroxyprogesterone acetate","volume":"6","author":"Kobayashi","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib58","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF00292875","article-title":"The pharmacokinetics of high-dose medroxyprogesterone acetate (MPA) in the therapy of advanced breast cancer","volume":"8","author":"Blossey","year":"1982","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib59","first-page":"813","article-title":"Medroxyprogesterone acetate: Variation in serum concentrations achieved with three commercially available preparations","volume":"71","author":"Stockdale","year":"1987","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib60","first-page":"199","article-title":"Liver function and medroxyprogesterone acetate elimination in man","volume":"38","author":"Rautio","year":"1984","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib61","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-199222050-00002","article-title":"Clinical pharmacokinetics of endocrine agents used in advanced breast cancer","volume":"22","author":"L\u00f8nning","year":"1992","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib62","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00228-006-0128-9","article-title":"Inhibitory effects of medroxyprogesterone acetate on human liver cytochrome P450 enzymes","volume":"62","author":"Zhang","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib63","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.contraception.2006.12.009","article-title":"Changes in weight with depot medroxyprogesterone acetate subcutaneous injection 104 mg\/0.65 mL","volume":"75","author":"Westhoff","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib64","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bjo.2007.114322","article-title":"Retinal venous occlusion associated with depot medroxyprogesterone acetate","volume":"91","author":"Deen","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib65","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.fertnstert.2006.11.040","article-title":"Effect of depomedroxyprogesterone acetate on coagulation parameters: A pilot study","volume":"87","author":"Goldstein","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib66","series-title":"Leuprolide Acetate and Triptorelin Pamoate Monographs. AHFS Drug Information 2008","first-page":"1136","year":"2008"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib67","series-title":"Lupron (leuprolide acetate suspension for injection and depot [3.75, 7.5, 11.25, 15, 22.5, and 30 mg] injection) [package insert]","year":"2000"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib68","series-title":"Eligard (leuprolide acetate for injectable suspension [7.5, 22.5, 30, and 45 mg depot injections]) [package insert]","year":"2006"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib69","series-title":"Trelstar Depot 3.75 mg and Trelstar LA (triptorelin pamoate suspension for infection) [package insert]","year":"2006"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib70","first-page":"1","article-title":"Triptorelin pamoate","volume":"3","year":"1993","journal-title":"Phase III Drug Profiles"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib71","first-page":"262","article-title":"Monthly administration of the LH-RH analogue decapeptyl for longterm treatment of ovarian dysfunctions and estrogen-dependent disorders","volume":"34","author":"Geisthoevel","year":"1989","journal-title":"Int J Fertil"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib72","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1365-2125.1997.t01-1-00592.x","article-title":"Pharmacokinetics of triptorelin after intravenous bolus administration in healthy males and in males with renal or hepatic insufficiency","volume":"44","author":"M\u00fcller","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib73","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/jps.2600750211","article-title":"Single-dose pharmacokinetics of leuprolide in humans following intravenous and subcutaneous administration","volume":"75","author":"Sennello","year":"1986","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib74","first-page":"433","article-title":"Successful treatment of hypersexuality in AIDS dementia with cyproterone acetate","volume":"81","author":"Potocnik","year":"1992","journal-title":"S Afr Med J"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib75","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1017\/S104161020300886X","article-title":"Lowdose cyproterone acetate treatment of sexual acting out in men with dementia","volume":"15","author":"Haussermann","year":"2003","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib76","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1192\/bjp.160.2.282","article-title":"Cyproterone acetate therapy and aggression","volume":"160","author":"Byrne","year":"1992","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib77","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1532-5415.2005.53126_9.x","article-title":"Optimizing antilibidinal treatment with medroxyprogesterone acetate","volume":"53","author":"Stewart","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib78","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1176\/ajp.145.9.1179","article-title":"Medroxyprogesterone acetate as a treatment for sexual acting out in organic brain syndrome","volume":"145","author":"Cooper","year":"1988","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib79","first-page":"132","article-title":"The use of medroxyprogesterone acetate for the treatment of sexually inappropriate behaviour in patients with dementia","volume":"31","author":"Light","year":"2006","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib80","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/089198879600900307","article-title":"Antiandrogen treatment of aggressivity in men suffering from dementia","volume":"9","author":"Amadeo","year":"1996","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib81","first-page":"368","article-title":"Medroxyprogesterone acetate (MPA) treatment of sexual acting out in men suffering from dementia","volume":"48","author":"Cooper","year":"1987","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib82","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0140-6736(92)90723-G","article-title":"Intramuscular medroxyprogesterone acetate for sexual aggression in elderly men","volume":"339","author":"Weiner","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib83","first-page":"54","article-title":"Transdermal estradiol in the management of aggressive behaviors in male patients with dementia","volume":"15","author":"Kay","year":"1995","journal-title":"Clin Gerontol"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib84","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1345\/aph.18237","article-title":"Estrogen for dementia-related aggression in elderly men","volume":"33","author":"Shelton","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib85","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1532-5415.1991.tb02878.x","article-title":"The use of estrogen to decrease aggressive physical behavior in elderly men with dementia","volume":"39","author":"Kyomen","year":"1991","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib86","first-page":"67","article-title":"Urethral masturbation and sexual disinhibition in dementia: A case report","volume":"40","author":"Rosenthal","year":"2003","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib87","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1532-5415.2000.tb04737.x","article-title":"Quetiapine for sexually inappropriate behavior in dementia","volume":"48","author":"MacKnight","year":"2000","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib88","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1176\/ajp.154.10.1474a","article-title":"Paroxetine treatment of sexual disinhibition in dementia","volume":"154","author":"Stewart","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib89","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/089198879500800210","article-title":"Clomipramine treatment of paraphilias in elderly demented patients","volume":"8","author":"Leo","year":"1995","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib90","first-page":"191","article-title":"Improvement in organically disturbed behavior with trazodone treatment","volume":"47","author":"Simpson","year":"1986","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib91","first-page":"510","article-title":"Short-term buspirone treatment in disinhibition with dementia","volume":"2","author":"Tiller","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib92","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1532-5415.1989.tb02278.x","article-title":"Hypersexual agitation in Alzheimer's disease","volume":"37","author":"Jensen","year":"1989","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib93","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1023\/B:UROL.0000020338.21912.c2","article-title":"Can gabapentin be a safe alternative to hormonal therapy in the treatment of inappropriate sexual behavior in demented patients?","volume":"35","author":"Alkhalil","year":"2003","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib94","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1055\/s-2005-864127","article-title":"Successful treatment of sexual disinhibition in dementia with carbamazepine\\3-a case report","volume":"38","author":"Freymann","year":"2005","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib95","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1046\/j.1532-5415.2003.514204.x","article-title":"Role of cholinesterase inhibitor in the management of sexual aggression in an elderly demented woman","volume":"51","author":"Alagiakrishnan","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib96","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1212\/WNL.54.10.2024","article-title":"Hypersexuality in patients with dementia: Possible response to cimetidine","volume":"54","author":"Wiseman","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib97","first-page":"174","article-title":"Estrogen therapy decreases physically aggressive behaviors in elderly long-term care facility dementia patients: Results from a double-blind, placebo-controlled clinical trial","volume":"9","author":"Kyomen","year":"1997","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib98","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/00926238508406076","article-title":"Antiandrogenic treatment of a gender-dysphoric transvestite","volume":"11","author":"Brantley","year":"1985","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib99","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4088\/JCP.v68n0314","article-title":"Antiaggressive effect of cyproterone versus haloperidol in Alzheimer's disease: A randomized double-blind pilot study","volume":"68","author":"Huertas","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib100","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1176\/ajp.150.4.673b","article-title":"Fetishism and clomipramine","volume":"150","author":"Clayton","year":"1993","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib101","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/107906320701900302","article-title":"Human rights and the treatment of sex offenders","volume":"19","author":"Ward","year":"2007","journal-title":"Sex Abuse"},{"key":"10.1016\/j.amjopharm.2008.12.004_bib102","first-page":"16","article-title":"The impact of surgical castration on sexual recidivism risk among sexually violent predatory offenders","volume":"33","author":"Weinberger","year":"2005","journal-title":"J Am Acad Psychiatry Law"}],"container-title":["The American Journal of Geriatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594608000755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594608000755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T12:10:19Z","timestamp":1558095019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1543594608000755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":102,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S1543594608000755"],"URL":"https:\/\/doi.org\/10.1016\/j.amjopharm.2008.12.004","relation":{},"ISSN":["1543-5946"],"issn-type":[{"value":"1543-5946","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}